stars 1 stars 2 stars 3

Syntensor is building software that converts large biological datasets into decisions. To predict clinical trial outcomes, the Syntensor platform first simulates a comprehensive suite of potency and ADMET assays; collectively, these two areas account for 60-70% of clinical trial failures. The model considers these predictions along with the burden of evidence for the drug's mechanism of action in the disease and trial design features to predict a probability of progression from one clinical trial stage to the next.

Syntensor Questions

Clayton Rabideau is the Founder, CEO of Syntensor.

9 people are employed at Syntensor.

Syntensor is based in San Francisco, California.

Top Syntensor Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users